Pfizer’s Braftovi (encorafenib) regimen has been granted accelerated approval by the US Food and Drug Administration (FDA) to ...

As the world’s third largest pharmaceutical market, Japan accounted for approximately 6% of the $1.5tn in global ...

If you are struggling to navigate the complexity of early commercialisation, rest assured, you are not alone. Clinical trial ...

AstraZeneca’s Tagrisso (osimertinib) has been approved by the European Commission (EC) to treat a new subset of lung cancer ...

Step into the future of medical education with our exclusive webinar series from February 25-26, designed specifically for Pharma leaders. This transformative series will showcase the 2025 Pharma ...

For many years the pharma sector has been vocal in its commitment to a ‘patient-focused’ approach. As a result, there does seem to be more attention on the patient across med affairs, marketing and ...

Is your medical education strategy reaching the right HCPs in the formats they prefer? Discover actionable insights to elevate the impact of your medical education efforts in the latest Medical ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a final call to marketing authorisation holders to ensure they are prepared to comply with the Windsor Framework arrangements ...

CHCR is a research centre offering healthcare communication consultancy, professional development and training including the first UK Postgraduate Certificate in Health Communications.